Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Steigelman
Mary Steigelman
Medicine
Follicular lymphoma
Immunology
Radioimmunotherapy
Lymphoma
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting
2016
Nuclear Medicine and Biology
Tarik Hadid
Ali Raufi
Zyad Kafri
Mary Mandziara
John Kalabat
Susan Szpunar
Kleanthe Kolizeras
Mary Steigelman
Ayad Al-Katib
Show All
Source
Cite
Save
Citations (7)
Pharmacokinetics of the BCL2-targeted DNA interference (DNAi) nanoparticle PNT2258 in patients with recurrent or refractory non-Hodgkin lymphoma.
2014
Journal of Clinical Oncology
Wael A. Harb
Nehal J. Lakhani
Ana Logsdon
Mary Steigelman
Heidi Smith-Green
Shari Kay Gaylor
Michael Woolliscroft
Wendi V. Rodrigueza
Mina Patel Sooch
Richard A. Messmann
Ayad Al-Katib
Show All
Source
Cite
Save
Citations (1)
1